Skip to main content
. 2012 Feb 15;7(2):e31073. doi: 10.1371/journal.pone.0031073

Figure 4. Inhibition of MS cholinergic pathway decreases the AMPA receptor activity in the CA1 pyramidal neurons of the hippocampus.

Figure 4

(A) Representatives of AMPA receptor mediated sEPSC traces in controls and 192-saporin infused rats recorded at −65 mV membrane potential; Calibration: 40 pA, 1 s. The adjacent average traces depict the reduction in the amplitude in the MS cholinergic lesioned rats compared to control rats, which show no difference in amplitude; Calibration: 15 pA, 30 ms. (B) Cumulative fraction plot of sEPSC amplitude from the composite data shows the shift of 192-saporin curve to the left from the controls, indicating reductions in amplitude. (C) Cumulative fraction plots of sEPSC interevent intervals exhibiting increased values for 192-saporin infused rats suggesting decreased frequency. (D) Representative traces of AMPA receptor mediated mEPSCs for the three groups (Calibration: 10 pA, 1 s) and the mEPSCs (Calibration: 10 pA, 30 ms) to show reduced amplitude in the 192-saporin infused rats. (E) Cumulative fraction plots for amplitude and (F) interevent interval exhibiting reduced amplitude and frequency.